Outcome of the Board held on 13th October, 2026.

ASSTON PHARMACEUTICALS LIMITED (FORMERLY KNOWN AS ASSTON PHARMACEUTICALS PRIVATE LIMITED) To, Date: 13th October, 2026 BSE Limited Listing / Compliance Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai, 400001 BSE Code: 544445 ISIN: INE0SJX01015 Sub: Outcome of Board Meeting for change in the Registered Office of the Company within the local limits of the same city and same Registrar of Companies. Dear Sir/ Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company at its meeting held today, i.e., Tuesday, 13th October 2026, which commenced at 04.00 P.M. and concluded at 04.20 P.M., has inter alia considered and approved: 1. For shifting the Registered Office of the Company: From: Office No. A-431, Balaji Bhavan, 4th Floor, Plot No 42A, Sector-11 CBD Belapur, Navi Mumbai, Maharashtra, 400614. To: Office No. 1437 and 1438, 24 High, Service Road, MIDC Industrial Area, Shiravane, Nerul, Navi Mumbai, Maharashtra – 410210. With effect from: 15th October 2026. Location: Within the local limits of the same city and under the jurisdiction of the same Registrar of Companies. Kindly take the same on record. Thanking you, For and on behalf of the Board of Directors Rishi Upadhaya Company Secretary & Compliance Officer A74324 CIN: U24304MH2019PLC324187 Reg. Office- 4th Floor Office No A-431 Balaji Bhavan, Plot No 42a Sector-11 CBD Belapur, Navi Mumbai, Thane, Maharashtra, 400614, India Phone No.: 022-49731419 / 49731411, Email id: aston.tech14@gmail.com/compliance@asstonpharmaceuticals.com Web: www.asstonpharmaceuticals.com